Recombinant Carnitine Palmitoyltransferase 2, Mitochondrial (CPT2) Rattus norvegicus (Rat) Recombinant protein

CPTASE; Carnitine O-Palmitoyltransferase 2; Carnitine palmitoyltransferase II

Add to Cart Distributors
Overview
Properties
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMitochondrion
  • Molecular Mass 26.6kDa, Accurate 27kDa(Analysis of differences refer to the manual)
  • Residues & TagsGly452~Thr658 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 97%
  • Isoelectric Point8.2
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Carnitine Palmitoyltransferase 2, Mitochondrial (CPT2) Packages (Simulation)
  • Recombinant Carnitine Palmitoyltransferase 2, Mitochondrial (CPT2) Packages (Simulation)
  • RPC417Ra01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Sequence

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiencyScienceDirect: S0022510X14000975
  • Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.pubmed:28127199

Recommend products